GlycoMimetics was founded in 2003 and is headquartered in Rockville, US

Chief Financial Officer

Director

Director

Director

Director

Chairman of the Board of Directors

GlycoMimetics has an office in Rockville

Rockville, US (HQ)

9708 Medical Center Dr

GlycoMimetics's revenue was reported to be $18.5 k in FY, 2016

USD

## Net income (Q1, 2017) | (7.9 m) |

## Market capitalization (25-Jul-2017) | 247.8 m |

## Cash (31-Mar-2017) | 34.6 m |

GlycoMimetics's current market capitalization is $247.8 m.

USD | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|

## Revenue | 15 m | 20.1 m | 18.5 k |

## Revenue growth, % | 34% | (100%) | |

## Operating expense total | 26.2 m | 32.9 m | |

## EBIT | (11.1 m) | (12.8 m) | |

## EBIT margin, % | (74%) | (64%) | |

## Net Income | (11.1 m) | (12.8 m) | (31.8 m) |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Net Income | 2.9 m | (3.7 m) | (7.1 m) | 3.3 m | (3.9 m) | (7.6 m) | (15.6 m) | (23.5 m) | (7.9 m) |

USD | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|

## Cash | 55.2 m | 46.8 m | 40 m |

## Accounts Receivable | 13.6 m | ||

## Inventories | 916.2 k | 441.8 k | 478.5 k |

## Current Assets | 56.1 m | 47.2 m | 40.5 m |

## PP&E | 452.3 k | 521.4 k | 1.1 m |

## Total Assets | 57.3 m | 48.5 m | 42.4 m |

## Accounts Payable | 874 k | 564.2 k | 1.6 m |

## Current Liabilities | 6.5 m | 7.7 m | 6.3 m |

## Total Liabilities | 7.1 m | ||

## Additional Paid-in Capital | 125.2 m | 127.6 m | 154.3 m |

## Retained Earnings | (74.4 m) | (87.2 m) | (119 m) |

## Total Equity | 50.8 m | 40.5 m | 35.3 m |

## Financial Leverage | 1.1 x | 1.2 x | 1.2 x |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Cash | 66.2 m | 61.4 m | 46.6 m | 40.2 m | 53.8 m | 38.8 m | 53.1 m | 45.3 m | 34.6 m |

## Accounts Receivable | 20 m | ||||||||

## Current Assets | 67.1 m | 61.9 m | 47.3 m | 60.8 m | 54.5 m | 39.5 m | 54.5 m | 46.5 m | 35.3 m |

## PP&E | 420.6 k | 481.9 k | 420.4 k | 579.2 k | 567.2 k | 491.4 k | 488 k | 676.6 k | 1.1 m |

## Total Assets | 67.5 m | 62.4 m | 48.5 m | 62 m | 55.7 m | 40.7 m | 55.8 m | 48 m | 37.2 m |

## Accounts Payable | 472.2 k | 583.7 k | 1.2 m | 1.1 m | 633.1 k | 1.6 m | 1.4 m | 1.2 m | 511.7 k |

## Current Liabilities | 3.6 m | 4.7 m | 4.1 m | 6.8 m | 6.9 m | 5.7 m | 6.1 m | 5.4 m | 4.5 m |

## Additional Paid-in Capital | 124.3 m | 124.7 m | 125.8 m | 126.3 m | 127 m | 129.5 m | 151.6 m | 152.4 m | 158.8 m |

## Retained Earnings | (60.4 m) | (67 m) | (81.5 m) | (71.1 m) | (78.3 m) | (94.7 m) | (102.8 m) | (110.6 m) | (126.9 m) |

## Total Equity | 63.9 m | 57.7 m | 44.4 m | 55.2 m | 48.7 m | 34.8 m | 48.9 m | 41.8 m | 31.9 m |

## Financial Leverage | 1.1 x | 1.1 x | 1.1 x | 1.1 x | 1.1 x | 1.2 x | 1.1 x | 1.1 x | 1.2 x |

USD | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|

## Net Income | (11.1 m) | (12.8 m) | (31.8 m) |

## Depreciation and Amortization | 158.7 k | 191.5 k | 190.5 k |

## Accounts Receivable | (1.9 m) | (1.7 m) | (1.9 m) |

## Inventories | 1.7 m | 474.4 k | (36.7 k) |

## Accounts Payable | (270.9 k) | (309.8 k) | 1 m |

## Cash From Operating Activities | 52.9 m | (8.4 m) | (29.7 m) |

## Purchases of PP&E | (212.6 k) | (268.6 k) | (704.2 k) |

## Cash From Investing Activities | (212.6 k) | (268.6 k) | (704.2 k) |

## Cash From Financing Activities | 57.4 m | 114.1 k | 23.7 m |

## Income Taxes Paid | 80 k | 80 k | 80 k |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Net Income | 2.9 m | (3.7 m) | (7.1 m) | 3.3 m | (3.9 m) | (7.6 m) | (15.6 m) | (23.5 m) | (7.9 m) |

## Depreciation and Amortization | 73.5 k | 114.3 k | 44.2 k | 90.5 k | 142.4 k | 47.2 k | 93.9 k | 139.7 k | 54.3 k |

## Accounts Receivable | (20 m) | ||||||||

## Accounts Payable | (672.7 k) | (561.2 k) | 299.5 k | 222.5 k | (240.9 k) | 1 m | 816.9 k | 682.5 k | (1.1 m) |

## Cash From Operating Activities | 6.6 m | 1.9 m | (8.7 m) | (14.8 m) | (1.3 m) | (9.2 m) | (16.3 m) | (23.8 m) | (9.1 m) |

## Purchases of PP&E | (95.7 k) | (197.7 k) | (2.3 k) | (207 k) | (265.4 k) | (17.3 k) | (40.3 k) | (265.6 k) | (63 k) |

## Cash From Investing Activities | (95.7 k) | (197.7 k) | (2.3 k) | (207 k) | (265.4 k) | (17.3 k) | (40.3 k) | (265.6 k) | (63 k) |

## Cash From Financing Activities | 57.4 m | 57.4 m | 75.4 k | 90.5 k | 110.7 k | 1.3 m | 22.6 m | 22.5 m | 3.7 m |

Y, 2017 | |
---|---|

## Financial Leverage | 1.2 x |